Since tumors have been described as “wounds that do not heal” [55], and TGF-β3 opposes the actions of TGF-β1 in normal wound healing [13], the high expression of TGF-β3 in breast cancer progression may be protective through suppression of aberrantly engaged or persistent wound healing responses. Here, TGFB1 is linked to breast carcinoma.